Governing Board
The Governing Board is the main decision-making body of the Innovative Medicines Initiative (IMI). It carries the overall responsibility for the operations of the undertaking and oversees the implementation of its activities. It therefore guarantees the fulfilment of the objectives set by the organisation.
The Governing Board is composed of 10 Board members representing equally our two Founding Members: 5 from the European Commission, representing the European Community, and 5 from the European Federation of Pharmaceutical Industries and Associations (EFPIA), representing the research-based pharmaceutical industry in Europe. In addition, our Associated Partners may take part in Governing Board discussions that concern their association, although they do not have voting rights.
The way the Governing Board works is set out in the Governing Board Rules of Procedure. Lists of the decisions taken by the Governing Board under the IMI2 programme are published on this page.
The roles of chair and deputy chair are held alternately by representatives of the European Commission and representatives of EFPIA.
Members of the IMI Governing Board
Representatives of the European Commission
Irene NORSTEDT
Chair of the IMI Governing Board
Director, People Directorate of the Directorate-General for Research and Innovation – DG RTD,
European Commission
Kristin Schreiber
Director - Ecosystems I: Chemicals, Food, Retail, Health within the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs – DG GROW,
European Commission
Andrzej Jan Rys
Director - Health systems, medical products and innovation within the Directorate-General for Health and Food Safety – DG SANTE,
European Commission
Barbara Kerstiëns
Head of Unit - ‘Combatting Diseases’ in the People Directorate of the Directorate-General for Research and Innovation – DG RTD,
European Commission
Carmen Laplaza Santos
Head of Unit - Health Innovations & Ecosystems within the Directorate-General for Research and Innovation – DG RTD,
European Commission
CV
Representatives of EFPIA
Olivier Laureau
Deputy Chair of the IMI Governing Board
President of Servier group
Salah-Dine Chibout
Global Head of Discovery and Investigational Safety at Novartis, Chairman of the EFPIA Research and Innovation Strategy Working Group
Jacky Vonderscher
CEO of Enyo Pharma S.A., member of the European Biopharmaceutical Enterprises Board
Paul Stoffels
Chief Scientific Officer at Johnson & Johnson, Worldwide Chairman of Janssen Pharmaceutical Companies of Johnson & Johnson
Alternate Members of the IMI Governing Board
Magda Chlebus Executive Director, Science Policy and Regulatory Affairs, EFPIA Declaration of interests
James Eshelby Vice President, Head of Global Public Private Partnerships, Pfizer Declaration of interests
Giacomo Mattinò European Commission, Head of Unit – Food, Retail, Health within the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs - DG GROW Declaration of interests
Sylvain Giraud European Commission, Head of Unit - Medical products: quality, safety, innovation within the Directorate-General for Health and Food Safety - DG SANTE Declaration of interests
Governing Board decisions
- List of decisions taken by the IMI2 Governing Board from 1 January to 31 December 2021
- List of decisions taken by the IMI2 Governing Board from 1 January to 31 December 2020
- List of decisions taken by the IMI2 Governing Board from 1 January to 31 December 2019
- List of decisions taken by the IMI2 Governing Board from 1 January to 31 December 2018
- List of decisions taken by the IMI2 Governing Board from 1 January to 31 December 2017
- List of decisions taken by the IMI2 Governing Board from 1 July to 31 December 2016
- List of decisions taken by the IMI2 Governing Board from 1 January to 30 June 2016
- List of decisions taken by the IMI2 Governing Board from 24 September to 31 December 2015
- List of decisions taken by the IMI2 Governing Board from 1 July to 23 September 2015
- List of decisions taken by the IMI2 Governing Board from 1 January to 30 June 2015
- List of decisions taken by the IMI2 Governing Board in 2014 (from the establishment of IMI2 JU on 27 June 2014 to the end of 2014)